FSBDX | VIGAX | FSBDX / VIGAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 11 years | 24 years | - |
Gain YTD | 2.067 | 1.326 | 156% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 12.5B | 284B | 4% |
Annual Yield % from dividends | 0.46 | 0.53 | 88% |
Returns for 1 year | 28.43 | 31.98 | 89% |
Returns for 3 years | 38.55 | 41.44 | 93% |
Returns for 5 years | 30.29 | 116.74 | 26% |
Returns for 10 years | 75.31 | 306.54 | 25% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PSET | 73.45 | 0.79 | +1.09% |
Principal Quality ETF | |||
UDEC | 35.49 | 0.17 | +0.50% |
Innovator U.S. Equity Ultra BffrETF™-Dec | |||
IHI | 61.84 | 0.23 | +0.37% |
iShares US Medical Devices ETF | |||
GPOW | 53.96 | N/A | N/A |
Goldman Sachs North Amr Pip & Pwr Eq ETF | |||
EUSB | 42.49 | N/A | N/A |
iShares ESG Advanced Ttl USD Bd Mrkt ETF |